Welcome to Multibagg AI
Log in to access personalized features
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Bearish
1
Neutral
7
Bullish
6
Bearish
5
Neutral
11
Bullish
30
Bearish
4
Neutral
4
Bullish
24
Discovery themes featuring this stock| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
32.75 | 71 Cr | -6.95 | 1.60 | 0.00 | -117.41 | -22.41 | -11.20 | ||
36.50 | 70 Cr | 8.70 | 1.02 | 0.00 | 11.07 | 11.52 | 10.35 | ||
112.95 | 67 Cr | 3.79 | 10.33 | 0.00 | 7.28 | 7.84 | 40.10 | ||
79.30 | 66 Cr | 33.20 | 1.70 | 0.00 | 0.00 | 0.00 | 4.00 | ||
214.00 | 65 Cr | -38.90 | 0.92 | 0.47 | 2.22 | 4.92 | -1.28 | ||
63.00 | 64 Cr | 22.33 | 1.25 | 0.00 | 2.54 | 6.69 | 1.80 | ||
8.90 | 62 Cr | 17.62 | 0.83 | 0.00 | 8.41 | 12.26 | 4.11 | ||
| Median: 7 Co. | — | 63.00 | 66 Cr | 8.70 | 1.25 | 0.00 | 2.54 | 6.69 | 4.00 |
Pharmaceuticals & Biotechnology
Pharmaceuticals
69 Cr
Low Risk
34.8
33.2
0.1
1.8
126.00
65.20
Sales CAGR
Profit CAGR
ROE
ROCE
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Asston Pharmaceuticals Ltd (APL) is currently trading at 81.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Asston Pharmaceuticals Ltd operates in the its sector sector. Review the About Company section on this page to understand its business model, revenue streams, and key products or services.
Over the past 52 weeks, Asston Pharmaceuticals Ltd has traded between a low of ₹65.20 and a high of ₹126.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Asston Pharmaceuticals Ltd has a market capitalization of approximately 68.95. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Asston Pharmaceuticals Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 34.82 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 68.95 Cr, Asston Pharmaceuticals Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Asston Pharmaceuticals Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Asston Pharmaceuticals Ltd is 34.82. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
EGM Auditor Appointment
Asston Pharmaceuticals held an EGM on 28-Apr-2026 via VC; Scrutinizer Pragya Jain submitted the voting results to BSE and shareholders approved the appointment of M/s Panchal SK & Associates as statutory auditors to fill a casual vacancy (record date 17-Apr-2026).
EGM proceedings
Asston Pharmaceuticals held an EGM on 28-Apr-2026 via VC to consider appointment of M/s Panchal SK & Associates as statutory auditors and regularisation of three directors; voting was conducted via remote e‑voting and results will be declared within 2 working days.
EGM Proceedings
Asston Pharmaceuticals held an EGM on 28‑Apr‑2026 via VC to appoint M/s Panchal SK & Associates as statutory auditors to fill a casual vacancy and to regularize three directors (two non‑executive non‑independent, one independent); voting was by remote e‑voting and results will be declared within 2 working days.
